Cargando…

Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)

BACKGROUND: Persons with human immunodeficiency virus (HIV) have higher risks for myocardial infarction (MI) than the general population. This is driven in part by higher type 2 MI (T2MI, due to coronary supply-demand mismatch) rates among persons with HIV (PWH). In the general population, T2MI has...

Descripción completa

Detalles Bibliográficos
Autores principales: Feinstein, Matthew J., Nance, Robin M., Delaney, J. A. Chris, Heckbert, Susan R., Budoff, Matthew J., Drozd, Daniel R., Burkholder, Greer A., Willig, James H., Mugavero, Michael J., Mathews, William C., Moore, Richard D., Eron, Joseph J., Napravnik, Sonia, Hunt, Peter W., Geng, Elvin, Hsue, Priscilla, Peter, Inga, Lober, William B., Crothers, Kristina, Grunfeld, Carl, Saag, Michael S., Kitahata, Mari M., Lloyd-Jones, Donald M., Crane, Heidi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668167/
https://www.ncbi.nlm.nih.gov/pubmed/31362721
http://dx.doi.org/10.1186/s12916-019-1385-7
_version_ 1783440172212289536
author Feinstein, Matthew J.
Nance, Robin M.
Delaney, J. A. Chris
Heckbert, Susan R.
Budoff, Matthew J.
Drozd, Daniel R.
Burkholder, Greer A.
Willig, James H.
Mugavero, Michael J.
Mathews, William C.
Moore, Richard D.
Eron, Joseph J.
Napravnik, Sonia
Hunt, Peter W.
Geng, Elvin
Hsue, Priscilla
Peter, Inga
Lober, William B.
Crothers, Kristina
Grunfeld, Carl
Saag, Michael S.
Kitahata, Mari M.
Lloyd-Jones, Donald M.
Crane, Heidi M.
author_facet Feinstein, Matthew J.
Nance, Robin M.
Delaney, J. A. Chris
Heckbert, Susan R.
Budoff, Matthew J.
Drozd, Daniel R.
Burkholder, Greer A.
Willig, James H.
Mugavero, Michael J.
Mathews, William C.
Moore, Richard D.
Eron, Joseph J.
Napravnik, Sonia
Hunt, Peter W.
Geng, Elvin
Hsue, Priscilla
Peter, Inga
Lober, William B.
Crothers, Kristina
Grunfeld, Carl
Saag, Michael S.
Kitahata, Mari M.
Lloyd-Jones, Donald M.
Crane, Heidi M.
author_sort Feinstein, Matthew J.
collection PubMed
description BACKGROUND: Persons with human immunodeficiency virus (HIV) have higher risks for myocardial infarction (MI) than the general population. This is driven in part by higher type 2 MI (T2MI, due to coronary supply-demand mismatch) rates among persons with HIV (PWH). In the general population, T2MI has higher mortality than type 1 MI (T1MI, spontaneous and generally due to plaque rupture and thrombosis). PWH have a greater burden of comorbidities and may therefore have an even greater excess risk for complication and death in the setting of T2MI. However, mortality patterns after T1MI and T2MI in HIV are unknown. METHODS: We analyzed mortality after MI among PWH enrolled in the multicenter, US-based Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort (N = 28,186). Incident MIs occurring between January 1, 1996, and December 31, 2014, were centrally adjudicated and classified as T1MI or T2MI. We first compared mortality following T1MI vs. T2MI among PWH. Cox survival analyses and Bayesian model averaging were then used to evaluate pre-MI covariates associated with mortality following T1MI and T2MI. RESULTS: Among the 596 out of 28,186 PWH who experienced MI (2.1%; 293 T1MI and 303 T2MI), mortality rates were significantly greater after T2MI (22.2/100 person-years; 1-, 3-, and 5-year mortality 39%, 52%, and 62%) than T1MI (8.2/100 person-years; 1-, 3-, and 5-year mortality 15%, 22%, and 30%). Significant mortality predictors after T1MI were higher HIV viral load, renal dysfunction, and older age. Significant predictors of mortality after T2MI were low body-mass index (BMI) and detectable HIV viral load. CONCLUSIONS: Mortality is high following MI for PWH and substantially greater after T2MI than T1MI. Predictors of death after MI differed by type of MI, reinforcing the different clinical scenarios associated with each MI type and the importance of considering MI types separately. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1385-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6668167
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66681672019-08-05 Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS) Feinstein, Matthew J. Nance, Robin M. Delaney, J. A. Chris Heckbert, Susan R. Budoff, Matthew J. Drozd, Daniel R. Burkholder, Greer A. Willig, James H. Mugavero, Michael J. Mathews, William C. Moore, Richard D. Eron, Joseph J. Napravnik, Sonia Hunt, Peter W. Geng, Elvin Hsue, Priscilla Peter, Inga Lober, William B. Crothers, Kristina Grunfeld, Carl Saag, Michael S. Kitahata, Mari M. Lloyd-Jones, Donald M. Crane, Heidi M. BMC Med Research Article BACKGROUND: Persons with human immunodeficiency virus (HIV) have higher risks for myocardial infarction (MI) than the general population. This is driven in part by higher type 2 MI (T2MI, due to coronary supply-demand mismatch) rates among persons with HIV (PWH). In the general population, T2MI has higher mortality than type 1 MI (T1MI, spontaneous and generally due to plaque rupture and thrombosis). PWH have a greater burden of comorbidities and may therefore have an even greater excess risk for complication and death in the setting of T2MI. However, mortality patterns after T1MI and T2MI in HIV are unknown. METHODS: We analyzed mortality after MI among PWH enrolled in the multicenter, US-based Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort (N = 28,186). Incident MIs occurring between January 1, 1996, and December 31, 2014, were centrally adjudicated and classified as T1MI or T2MI. We first compared mortality following T1MI vs. T2MI among PWH. Cox survival analyses and Bayesian model averaging were then used to evaluate pre-MI covariates associated with mortality following T1MI and T2MI. RESULTS: Among the 596 out of 28,186 PWH who experienced MI (2.1%; 293 T1MI and 303 T2MI), mortality rates were significantly greater after T2MI (22.2/100 person-years; 1-, 3-, and 5-year mortality 39%, 52%, and 62%) than T1MI (8.2/100 person-years; 1-, 3-, and 5-year mortality 15%, 22%, and 30%). Significant mortality predictors after T1MI were higher HIV viral load, renal dysfunction, and older age. Significant predictors of mortality after T2MI were low body-mass index (BMI) and detectable HIV viral load. CONCLUSIONS: Mortality is high following MI for PWH and substantially greater after T2MI than T1MI. Predictors of death after MI differed by type of MI, reinforcing the different clinical scenarios associated with each MI type and the importance of considering MI types separately. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1385-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-07-31 /pmc/articles/PMC6668167/ /pubmed/31362721 http://dx.doi.org/10.1186/s12916-019-1385-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Feinstein, Matthew J.
Nance, Robin M.
Delaney, J. A. Chris
Heckbert, Susan R.
Budoff, Matthew J.
Drozd, Daniel R.
Burkholder, Greer A.
Willig, James H.
Mugavero, Michael J.
Mathews, William C.
Moore, Richard D.
Eron, Joseph J.
Napravnik, Sonia
Hunt, Peter W.
Geng, Elvin
Hsue, Priscilla
Peter, Inga
Lober, William B.
Crothers, Kristina
Grunfeld, Carl
Saag, Michael S.
Kitahata, Mari M.
Lloyd-Jones, Donald M.
Crane, Heidi M.
Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)
title Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)
title_full Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)
title_fullStr Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)
title_full_unstemmed Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)
title_short Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)
title_sort mortality following myocardial infarction among hiv-infected persons: the center for aids research network of integrated clinical systems (cnics)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668167/
https://www.ncbi.nlm.nih.gov/pubmed/31362721
http://dx.doi.org/10.1186/s12916-019-1385-7
work_keys_str_mv AT feinsteinmatthewj mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT nancerobinm mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT delaneyjachris mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT heckbertsusanr mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT budoffmatthewj mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT drozddanielr mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT burkholdergreera mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT willigjamesh mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT mugaveromichaelj mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT mathewswilliamc mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT moorerichardd mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT eronjosephj mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT napravniksonia mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT huntpeterw mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT gengelvin mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT hsuepriscilla mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT peteringa mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT loberwilliamb mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT crotherskristina mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT grunfeldcarl mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT saagmichaels mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT kitahatamarim mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT lloydjonesdonaldm mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics
AT craneheidim mortalityfollowingmyocardialinfarctionamonghivinfectedpersonsthecenterforaidsresearchnetworkofintegratedclinicalsystemscnics